173 related articles for article (PubMed ID: 20649994)
1. Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.
Chan HH; Chu TH; Chien HF; Sun CK; Wang EM; Pan HB; Kuo HM; Hu TH; Lai KH; Cheng JT; Tai MH
BMC Gastroenterol; 2010 Jul; 10():83. PubMed ID: 20649994
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
Chu TH; Chan HH; Hu TH; Wang EM; Ma YL; Huang SC; Wu JC; Chang YC; Weng WT; Wen ZH; Wu DC; Chen YA; Tai MH
Cancer Med; 2018 Jun; 7(6):2567-2580. PubMed ID: 29683262
[TBL] [Abstract][Full Text] [Related]
3. Effects of sinomenine on a rat orthotopic liver carcinoma model.
Zhang Y; Ran H; Hui S; Qian L
Histol Histopathol; 2024 Jun; 39(6):795-804. PubMed ID: 38084512
[TBL] [Abstract][Full Text] [Related]
4. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice.
Ling N; Zhou X; Ji Y; Li W; Ji C; Qi Z
Biomed Pharmacother; 2017 Jul; 91():132-137. PubMed ID: 28448867
[TBL] [Abstract][Full Text] [Related]
5. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
6. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL.
Chang WT; Hsieh BS; Cheng HL; Lee KT; Chang KL
J Surg Res; 2014 May; 188(2):432-41. PubMed ID: 24594218
[TBL] [Abstract][Full Text] [Related]
7. Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma.
Pohl J; Zuna I; Stremmel W; Rudi J
Chemotherapy; 2001; 47(5):359-65. PubMed ID: 11561139
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
9. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
10. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Lin ZY; Chuang WL; Chuang YH; Yu ML; Hsieh MY; Wang LY; Tsai JF
J Gastroenterol Hepatol; 2006 Feb; 21(2):398-405. PubMed ID: 16509865
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.
Solorio L; Wu H; Hernandez C; Gangolli M; Exner AA
Ther Deliv; 2016; 7(4):201-12. PubMed ID: 27010983
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.
Wen X; Reynolds L; Mulik RS; Kim SY; Van Treuren T; Nguyen LH; Zhu H; Corbin IR
Gastroenterology; 2016 Feb; 150(2):488-98. PubMed ID: 26484708
[TBL] [Abstract][Full Text] [Related]
13. Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.
Lin LW; Lin XD; He YM; Gao SD; Xue ES
World J Gastroenterol; 2003 Apr; 9(4):701-5. PubMed ID: 12679914
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy.
Jaroszeski MJ; Coppola D; Pottinger C; Benson K; Gilbert RA; Heller R
Eur J Cancer; 2001 Feb; 37(3):422-30. PubMed ID: 11239766
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells.
Xi S; Hong R; Huang J; Lu D; Qian L; Li P; Wen L; Wang Y
Afr J Tradit Complement Altern Med; 2014; 11(4):94-100. PubMed ID: 25392588
[TBL] [Abstract][Full Text] [Related]
16. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Huynh H; Ong R; Soo KC
Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
[TBL] [Abstract][Full Text] [Related]
17. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
18. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 is increased in anticancer drug-containing media and hypoxic cultures, similar to TACE.
Mamori S; Tajiri H
Scand J Gastroenterol; 2009; 44(4):507-8. PubMed ID: 19107674
[No Abstract] [Full Text] [Related]
20. Development of an immunosuppressed orthotopic hepatocellular carcinoma rat model for the evaluation of chemo- and radioembolization therapies.
Charles L; Sekar S; Osooly M; Javed S; Williams KC; Welch I; Barta I; Saatchi K; Häfeli UO
Eur J Pharm Biopharm; 2024 Mar; 196():114180. PubMed ID: 38237643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
